Abstract:The problem of antibiotic resistance has become a challenge for our public health and society; it has allowed infectious diseases to re-emerge as a risk to human health. New antibiotics that are introduced to the market face the rise of resistant pathogens after a certain period of use. The relatively fast development of resistance against some antibiotics seems to be closely linked to their microbial origin and function in nature. Antibiotics in clinical use are merely products of microorganisms or derivatives of microbial products. The evolution of these antimicrobial compounds has progressed with the evolution of the respective resistance mechanisms in microbes for billions of years. Thus, antimicrobial resistance genes are present within the environment and can be taken up by pathogens through horizontal gene transfer. Natural products from bacteria are an important source of leads for drug development, and microbial natural products have contributed the most antibiotics in current clinical use. Bioprospecting for new antibiotics is a labor-intensive task as obstacles such as redetection of known compounds and low compound yields consume significant resources. The number of bacterial isolates one can theoretically investigate for new secondary metabolites is, on the other hand, immense. Therefore, the available capacity for biodiscovery should be focused on the most promising sources for chemical novelty and bioactivity, employing the appropriate scientific tools. This can be done by first looking into under- or unexplored environments for bacterial isolates and by focusing on the promising candidates to reduce the number of subjects.

New antibiotics from bacterial natural products

Antibiotics for Emerging Pathogens

The re-emerging role of microbial natural products in antibiotic discovery

Alternative natural sources for a new generation of antibacterial agents

Recent progress of antibacterial natural products: Future antibiotics candidates

Bacterial Natural Product Drug Discovery for New Antibiotics: Strategies for Tackling the Problem of Antibiotic Resistance by Efficient Bioprospecting

Harnessing Gram‐negative bacteria for novel anti‐Gram‐negative antibiotics

Genome mining and prospects for antibiotic discovery

Sophisticated natural products as antibiotics

Towards the sustainable discovery and development of new antibiotics

Natural Products Resolve Antibiotic Resistance Crisis

Streptomyces from traditional medicine: sources of new innovations in antibiotic discovery

Natural products acting against S. aureus through membrane and cell wall disruption

Newer antibacterial drugs for a new century

Semisynthesis: An Essential Tool for Antibiotics Drug Discovery

Using bacterial genomes and essential genes for the development of new antibiotics

Actinomycetes: still a source of novel antibiotics

Forgotten Natural Products: Semisynthetic Development of Blasticidin S As an Antibiotic Lead

Biosynthesis of C-nucleoside antibiotics in actinobacteria: recent advances and future developments

Discovering new bioactive molecules from microbial sources

Natural antibiotics against antimicrobial resistance: sources and bioinspired delivery systems